Gloves and socks syndrome associated with parvovirus B19 infection.

Acta Dermatovenerol Croat

Anita Hryncewicz-Gwozdz, MD, ul. Chałubińskiego 1, Wrocław 50-368 , Poland.

Published: January 2007

The spectrum of disease caused by parvovirus B19 infection ranges from asymptomatic to a serious disease. Parvovirus B19 plays a role in the pathomechanism of gloves and socks syndrome, erythema infectiosum, acute polyarthralgia, aplastic crisis in persons with hemolytic anemia, and birth defects. Gloves and socks syndrome has an acute febrile course. Painful edema of hands and feet, and numerous small confluent petechiae in the same localization are the most characteristic signs. Blisters and erosions may occur in oral mucosa. General discomfort and arthralgia accompany skin lesions. The disease tends to be self-limiting. A typical case of gloves and socks syndrome in a 36-year-old woman is reported. Serological tests disclosed the parvovirus B19 infection, confirming the causal relationship between the syndrome and this infection.

Download full-text PDF

Source

Publication Analysis

Top Keywords

gloves socks
16
socks syndrome
16
parvovirus b19
16
b19 infection
12
syndrome
5
gloves
4
syndrome associated
4
parvovirus
4
associated parvovirus
4
b19
4

Similar Publications

Cotton undergarments as a tool for polycyclic aromatic hydrocarbons whole body dosimetry of firefighters.

J Occup Environ Hyg

January 2025

Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University Bochum (IPA), Bochum, Germany.

Firefighters are exposed to a variety of hazardous substances during firefighting activities. Fire smoke contains polycyclic aromatic hydrocarbons (PAHs) some of which have been shown to cause cancer in humans. To assess dermal exposure of firefighters during real-life firefighting, a whole-body dosimetry method was applied to determine the PAH that settles on the skin despite firefighters wearing personal protective equipment (PPE).

View Article and Find Full Text PDF

Purpose: The study investigates cryotherapy's efficacy in mitigating Chemotherapy-induced peripheral neuropathy (CIPN), an adverse effect of chemotherapy that often leads to dosage reduction or treatment discontinuation.

Method: The study was registered with PROSPERO (CRD42023428936). A literature search was conducted using the PubMed, Embase, and Cochrane Library databases.

View Article and Find Full Text PDF

Background Chemotherapy-induced peripheral neuropathy (CIPN) is a problematic adverse event for breast cancer patients receiving taxane antimitotic agents. We evaluated the effectiveness of compression therapy against CIPN in the lower extremities of breast cancer patients receiving taxanes. Methods Eligible patients scheduled for perioperative treatment with taxanes for early-stage breast cancer were enrolled.

View Article and Find Full Text PDF
Article Synopsis
  • - The study aimed to investigate the impact of compression therapy on chemotherapy-induced peripheral neuropathy (CIPN), anxiety, depression, and sleep disorders in breast cancer patients receiving taxane chemotherapy.
  • - Eighty patients were split into a control group receiving standard care and an intervention group that also received compression therapy during chemotherapy, with assessments made before and after the treatment cycles.
  • - Results showed that after the fourth and sixth cycles, the intervention group had significantly lower levels of CIPN, anxiety, depression, and improved sleep scores compared to the control group, suggesting that compression therapy is beneficial for patients undergoing chemotherapy.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!